OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
November 02, 2015
CDMO Xcelience opens new facility in Tampa, FL, for formulation and analytical services.
October 30, 2015
New instrumentation at the SGS Mississauga, Canada facility advances testing capabilities for packaging and container testing.
October 20, 2015
Closing the summer of 2015, the ChemOutsourcing conference examined contract services from both a sponsor’s and a CMO or CRO’s perspective
October 16, 2015
The two companies will combine life-sciences marketing and a consulting firm to create a life sciences-centered consulting service.
October 15, 2015
Scottish injectable-drug manufacturer Symbiosis Pharmaceutical Services plans to expand its sterile filling facility.
CDMO Aesica Pharmaceuticals introduced a new service approach in which the company will taks on the management of other CDMOs, while serving as the single, central point of customer contact, the company announced in an Oct. 14, 2015 press release.
October 13, 2015
In the past, contract manufacturing organizations (CMOs) and contract development manufacturing organizations (CDMOs) have been focused most on achieving scale, reaching new clients in new geographic regions, and adding services that were previously unavailable, according to Gil Y. Roth, president of the Pharma and Biopharma Outsourcing Association. In a new report from CPhI, Roth explicates how consolidation has changed how CMOs position their services to clients and how CMOs add value to their businesses.
Upgrades to Mettler Toledo’s weighing and dosing equipment increase productivity using lean laboratory principles.
Cell Therapy Catapult will provide manufacturing scale-up services to enable Asterias’ future clinical trials and commercial supply for Asterias’ allogeneic dendritic cell immunotherapy, AST-VAC2.
October 08, 2015
Contract manufacturer PiazaBio announces services for Western Pharma companies seeking to enter the China market.